Influence of age and shock severity on short-term survival in patients with cardiogenic shock. Issue 6 (4th January 2021)

• Record Type: Journal Article
• Authors: Jentzer, Jacob C; Schrage, Benedikt; Holmes, David R; Dabboura, Salim; Anavekar, Nandan S; Kirchhof, Paulus; Barsness, Gregory W; Blankenberg, Stefan; Bell, Malcolm R; Westermann, Dirk
• Is Part Of: European heart journal. Volume 10:Issue 6(2021)
• Page Start: 604
• Page End: 612
• Publication Date: 2021-01-04
• Subjects: Age -- Cardiogenic shock -- Frailty -- Survival -- Shock; 616.1205
• DOI: 10.1093/ehjacc/zuaa035
• Languages: English
• ISSNs: 2048-8726

Abstract

Abstract: Aims: Cardiogenic shock (CS) is associated with poor outcomes in older patients, but it remains unclear if this is due to higher shock severity. We sought to determine the associations between age and shock severity on mortality among patients with CS. Methods and results: Patients with a diagnosis of CS from Mayo Clinic (2007–15) and University Clinic Hamburg (2009–17) were subdivided by age. Shock severity was graded using the Society for Cardiovascular Angiography and Intervention (SCAI) shock stages. Predictors of 30-day survival were determined using Cox proportional-hazards analysis. We included 1749 patients (934 from Mayo Clinic and 815 from University Clinic Hamburg), with a mean age of 67.6 ± 14.6 years, including 33.6% females. Acute coronary syndrome was the cause of CS in 54.0%. The distribution of SCAI shock stages was 24.1%; C, 28.0%; D, 33.2%; and E, 14.8%. Older patients had similar overall shock severity, more co-morbidities, worse kidney function, and decreased use of mechanical circulatory support compared to younger patients. Overall 30-day survival was 53.3% and progressively decreased as age or SCAI shock stage increased, with a clear gradient towards lower 30-day survival as a function of increasing age and SCAI shock stage. Progressively older age groups had incrementally lower adjusted 30-day survival than patients aged <50 years. Conclusion: Older patients with CS have lower short-term survival, despite similar shock severity, with a high risk of death in older patients with more severe shock. Further research is needed to determine the optimal treatment strategies for older CS patients.